Two Sigma Investments’s SQZ Biotechnologies Company SQZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,620
Closed -$31K 3176
2022
Q3
$31K Sell
13,620
-112
-0.8% -$336 ﹤0.01% 2355
2022
Q2
$44K Sell
13,732
-25,960
-65% -$93.4K ﹤0.01% 2358
2022
Q1
$191K Sell
39,692
-7,489
-16% -$47.5K ﹤0.01% 2347
2021
Q4
$421K Buy
47,181
+4,768
+11% +$58.4K ﹤0.01% 3407
2021
Q3
$612K Buy
42,413
+10,142
+31% +$137K ﹤0.01% 3064
2021
Q2
$466K Sell
32,271
-10,922
-25% -$143K ﹤0.01% 3170
2021
Q1
$591K Buy
+43,193
New +$877K ﹤0.01% 2783

Other funds holding SQZ

Two Sigma Investments's SQZ Position: Q4 2022 in Review

Two Sigma Investments sold out of SQZ Biotechnologies Company (SQZ) in Q4 2022, closing a stake of 13,620 shares — an estimated $31K sold.

Two Sigma Investments first reported a position in SQZ in Q1 2021 and held it in 7 quarters. The position peaked at $612K in Q3 2021. 36 funds tracked by Wall St. Rank hold SQZ as of Q4 2022.

  • Two Sigma Investments reported no remaining SQZ Biotechnologies Company position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Investments sold 13,620 SQZ Biotechnologies Company shares in Q4 2022, an estimated $31K.
  • Two Sigma Investments first reported a position in SQZ Biotechnologies Company in Q1 2021 and held it in 7 quarters.
  • Two Sigma Investments's SQZ Biotechnologies Company position peaked at $612K in Q3 2021.
  • 36 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q4 2022.

Based on Two Sigma Investments's 13F filing for Q4 2022, filed 14 Feb 2023.